Judith A.M. Wessels

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritis

Judith A.M. Wessels, S M van der Kooij, Saskia le Cessie et al. · Arthritis & Rheumatism · 2007 · 242 citations

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single‐nucleotide polymorphisms in genes coding for folate pathway enzymes

Judith A.M. Wessels, Jeska K de Vries‐Bouwstra, B.T. Heijmans et al. · Arthritis & Rheumatism · 2006 · 206 citations

Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

Nielka P. van Erp, Karel Eechoute, A. A. van der Veldt et al. · Journal of Clinical Oncology · 2009 · 183 citations

Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib

Astrid A.M. van der Veldt, Karel Eechoute, Hans Gelderblom et al. · Clinical Cancer Research · 2010 · 156 citations

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

H M Albers, Judith A.M. Wessels, R.J.H.M. van der Straaten et al. · Arthritis Care & Research · 2008 · 136 citations